Differentiating Combined Hepatocellular and Cholangioc cinoma from Mass-Forming Intrahepatic Chol gioc cinoma Using Gadoxetic Acid-Enh ced MRI

被引:71
作者
Hwang, Jiyoung
Kim, Young Kon [1 ,2 ]
Park, Min Jung
Lee, Mi Hee
Kim, Seong Hyun
Lee, Won Jae
Rhim, Hyun Chul
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea
关键词
CLINICAL-FEATURES; CARCINOMA; LIVER; EFFICACY; CT;
D O I
10.1002/jmri.23728
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To examine the differential features of combined hepatocellular and cholangiocarcinoma (HCC-CC) from mass-forming intrahepatic cholangiocarcinoma (ICC) on gadoxetic acid-enhanced MRI. Materials and Methods: Forty patients with pathologically proven combined HCC-CC (n = 20) and ICCs (n = 20) who had undergone gadoxetic acid-enhanced MRI were enrolled in this study. MR images were analyzed for the shape of lesions, hypo- or hyperintense areas on the T2-weighted image (T2WI), rim enhancement during early dynamic phases, and central enhancement with hypointense rim (target appearance) on the 10-min and 20-min hepatobiliary phase (HBP). The significance of these findings was determined by the χ2 test. Results: Irregular shape and strong rim enhancement during early dynamic phases, and absence of target appearance on HBP favored combined HCC-CCs (P < 0.05). Lobulated shape, weak peripheral rim enhancement, and the presence of complete target appearance on the 10-min and 20-min HBP favored ICCs (P < 0.05). However, 10 CC-predominant type of combined HCC-CC showed complete or partial target appearance on 10-min HBP. Conclusion: The shape of tumors, degree of rim enhancement during early dynamic phases, and target appearance on HBP were valuable for differentiating between combined HCC-CC and mass-forming ICC on gadoxetic acid-enhanced MRI. © 2012 Wiley Periodicals, Inc.
引用
收藏
页码:881 / 889
页数:9
相关论文
共 29 条
[21]   Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma [J].
Lee, Won-Suk ;
Lee, Kwang-Woong ;
Heo, Jin-Seok ;
Kim, Sung-Ju ;
Choi, Seong-Ho ;
Kim, Yong-Il ;
Joh, Jae-Won .
SURGERY TODAY, 2006, 36 (10) :892-897
[22]   Cholangiocarcinoma: Morphologic classification according to growth pattern and imaging findings [J].
Lim, JH .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 181 (03) :819-827
[23]   MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation [J].
Maetani, Y ;
Itoh, K ;
Watanabe, C ;
Shibata, T ;
Ametani, F ;
Yamabe, H ;
Konishi, J .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 176 (06) :1499-1507
[24]  
Masamichi K, 2006, PATHOLOGY HEPATOCELL, P105
[25]   Cholangiocarcinoma in Cirrhosis: Absence of Contrast Washout in Delayed Phases by Magnetic Resonance Imaging Avoids Misdiagnosis of Hepatocellular Carcinoma [J].
Rimola, Jordi ;
Forner, Alejandro ;
Reig, Maria ;
Vilana, Ramon ;
Rodriguez de Lope, Carlos ;
Ayuso, Carmen ;
Bruix, Jordi .
HEPATOLOGY, 2009, 50 (03) :791-798
[26]   A clinicopathological study on combined hepatocellular and cholangiocarcinoma [J].
Taguchi, J ;
Nakashima, O ;
Tanaka, M ;
Hisaka, T ;
Takazawa, T ;
Kojiro, M .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1996, 11 (08) :758-764
[27]   MR IMAGING OF PERIPHERAL CHOLANGIOCARCINOMA [J].
TANI, K ;
KUBOTA, Y ;
YAMAGUCHI, T ;
KITAGAWA, S ;
KATOH, T ;
SEKI, T ;
MIZUNO, T ;
INOUE, K .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1991, 15 (06) :975-978
[28]  
Theise ND., 2010, WHO Classification of Tumours of the Digestive System, V4th, P225
[29]   Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients [J].
Vilgrain, V ;
VanBeers, BE ;
Flejou, JF ;
Belghiti, J ;
Delos, M ;
Gautier, AL ;
Zins, M ;
Denys, A ;
Menu, Y .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1997, 21 (01) :59-65